Tuberculosis News and Research

Latest Tuberculosis News and Research

VOA News examines malaria in southern Sudan

VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.

29 Jun 2009

Lancet Infectious Diseases examines spread of XDR-TB

The journal Lancet Infectious Diseases examines the worldwide spread of extensively drug-resistant tuberculosis (XDR-TB). Currently, about 500,000 of the 9 million new cases of TB that are identified each year are strains of XDR-TB. "Drug resistance is largely man-made - it is vitally important to review antibiotic treatment strategies and to ensure the Stop TB Strategy is fully applied to prevent further selection of drug-resistant mutants," Leonard Amaral of Universidade Nova de Lisboa said.

24 Jun 2009

NewsHour features two health experts on President Obama's global health initiative

On the NewsHour Insider Forum, Ray Suarez interviews global health experts Michele Moloney-Kitts, assistant U.S. global AIDS coordinator, and Christine Lubinski, head of the Center for Global Health Policy and Advocacy about President Obama's $63 billion global health initiative.

24 Jun 2009

New tuberculosis drug targets

A fundamental question about how sugar units are strung together into long carbohydrate chains has also pinpointed a promising way to target new medicines against tuberculosis.

23 Jun 2009

Some call for more action at conclusion of Pacific Health Summit

Some Pacific Health Summit attendees said more action should have come from the tuberculosis-focused conference, which ended on Thursday in Seattle, Seattle Times' "Business of Giving" blog reports.

21 Jun 2009

Lancet studies examine aspects of global health funding

"Global health funding boosted by private donors has quadrupled since 1990, but the extra money has not always gone to the right countries and diseases, according to a pair of studies released Friday," in the journal Lancet, AFP/Google.com reports (Hood, AFP/Google.com, 6/18).

21 Jun 2009

Tibotec, TB Alliance join to expedite development of promising tuberculosis drug

The pharmaceutical company Tibotec said it will join with the non-profit Global Alliance for Tuberculosis Development (TB Alliance) to speed up the development of the experimental TB drug TMC207, Health-e/IOL reports (Thom, Health-e/IOL, 6/18). Tibotec, which is a subsidiary of Johnson & Johnson, announced the news on Wednesday at the Pacific Health Summit in Seattle (Doughton, Seattle Times, 6/18).

18 Jun 2009

House State-Foreign Operations Appropriations Subcommittee approves FY10 funding measure

The House State-Foreign Operations Appropriations Subcommittee "unanimously approved its FY10 funding measure without any amendments" on Wednesday, "deferring expected fights for the full committee markup in a week," CongressDaily reports.

18 Jun 2009

Six 'major health agencies' form alliance to address chronic diseases in developing countries

A group of "major health agencies" from Australia, Canada, China, the U.K. and the U.S., which "together control 80 percent of the world's public health-research funding," have joined together to form the Global Alliance for Chronic Diseases (GACD) to combat chronic diseases in developing countries, Time reports (Walsh, Time, 6/16).

17 Jun 2009

Distributed drug discovery for neglected diseases

Researchers from Indiana University-Purdue University Indianapolis (IUPUI) have developed Distributed Drug Discovery (D3), a new low-cost strategy to accelerate the discovery of drugs to treat neglected diseases such as tuberculosis, leprosy, leshmaniasis, dengue fever, and Chagas disease.

16 Jun 2009

Access issues persist for Indians, rural Americans, immigrants

Several reports today focus on inadequate health care for certain population groups within the United States.

15 Jun 2009

South African AIDS advocate who created radio diaries dies of drug-resistant tuberculosis

South African AIDS activist Thembi Ngubane recently died of drug-resistant tuberculosis at the age of 24, the AP/Washington Post reports (Nullis, AP/Washington Post, 6/14).

15 Jun 2009

Reuters examines WHO efforts to fight H1N1 in developing countries

Reuters examines the WHO's battle against the H1N1 (swine flu) virus in "[d]eveloping countries, where medical care systems are weak and supplies of antivirals insufficient." In addition to "supplying countries with diagnostic kits, medicines and masks and gloves to protect health care workers and minimize the further spread of the new virus," the WHO is continuing to distribute doses of the antiviral Tamiflu, which has been "shown to be effective so far against H1N1," according to Reuters.

15 Jun 2009

Boston Globe examines the U.S. strategy towards global health

The Boston Globe examines the U.S. strategy towards global health aid. "President George W. Bush scored major advances in his administration's worldwide campaign against AIDS," and "[t]he Obama administration believes it can leverage Bush's successes into an assault against a much broader array of diseases that afflict poor countries," writes the Globe.

15 Jun 2009

Recent releases: HIV prevention; clinical trials debate; definition of global health; drug resistant tuberculosis

In a Journal of the American Medical Association commentary piece, Anthony Fauci and Carl Dieffenbach of the National Institute of Allergy and Infectious Diseases explore results from a WHO mathematical model study that found universal, voluntary, annual HIV testing followed up with immediate treatment for those testing positive -- the "test and treat model" -- could "reduce HIV incidence" and "end the [HIV] pandemic within 50 years."

13 Jun 2009

Wall Street Journal examines program to spur vaccine development for developing world diseases

The Wall Street Journal examines a $1.5 billion program supported by Italy, the U.K., Canada, Russia, Norway and the Bill & Melinda Gates Foundation that hopes "to encourage pharmaceutical companies to develop vaccines for diseases common to poor countries," which is expected to be announced Friday "on the sidelines of a meeting of top finance officials from the Group of Eight major industrial powers."

13 Jun 2009

Progress seen in some African HIV/AIDS prevention, treatment programs, U.N. Special Envoy says at World Economic Forum on Africa

Several African countries have successfully scaled up their HIV/AIDS prevention and treatment programs, U.N. Special Envoy for HIV and AIDS in Africa Elizabeth Mataka said during a media briefing at the World Economic Forum on Africa being held in Cape Town, South Africa, the ZANIS/Lusaka Times reports. Zambia and Botswana were among some of the countries that have made significant progress in southern Africa, according to Mataka.

13 Jun 2009

Women, girls priority in U.S. efforts against global HIV/AIDS, Clinton tells international health experts

In a video address to international HIV/AIDS experts gathered in Namibia for the 2009 HIV/AIDS Implementers Meeting Wednesday, U.S. Secretary of State Hillary Rodham Clinton emphasized the Obama administration's commitment to women and girls in the fight against HIV/AIDS, the AP/Washington Post reports.

11 Jun 2009

Antiretroviral therapy earlier yields better clinical outcomes

A clinical trial has demonstrated that HIV-infected adults in a resource-limited setting are more likely to survive if they start antiretroviral therapy (ART) before their immune systems are severely compromised.

9 Jun 2009

Jacob Zuma addresses increased access to antiretrovirals, reduction in HIV incidence

South African President Jacob Zuma on Wednesday said he wants to have 80 percent of HIV-positive South Africans who need antiretrovirals (ARVs) on them by 2011, BuaNews reports (BuaNews/allAfrica.com, 6/3).

9 Jun 2009

Tuberculosis News and Research

Latest Tuberculosis News and Research

VOA News examines malaria in southern Sudan

Lancet Infectious Diseases examines spread of XDR-TB

NewsHour features two health experts on President Obama's global health initiative

New tuberculosis drug targets

Some call for more action at conclusion of Pacific Health Summit

Lancet studies examine aspects of global health funding

Tibotec, TB Alliance join to expedite development of promising tuberculosis drug

House State-Foreign Operations Appropriations Subcommittee approves FY10 funding measure

Six 'major health agencies' form alliance to address chronic diseases in developing countries

Distributed drug discovery for neglected diseases

Access issues persist for Indians, rural Americans, immigrants

South African AIDS advocate who created radio diaries dies of drug-resistant tuberculosis

Reuters examines WHO efforts to fight H1N1 in developing countries

Boston Globe examines the U.S. strategy towards global health

Recent releases: HIV prevention; clinical trials debate; definition of global health; drug resistant tuberculosis

Wall Street Journal examines program to spur vaccine development for developing world diseases

Progress seen in some African HIV/AIDS prevention, treatment programs, U.N. Special Envoy says at World Economic Forum on Africa

Women, girls priority in U.S. efforts against global HIV/AIDS, Clinton tells international health experts

Antiretroviral therapy earlier yields better clinical outcomes

Jacob Zuma addresses increased access to antiretrovirals, reduction in HIV incidence

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Tuberculosis News and Research

Latest Tuberculosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in